US SB3722 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on May 13 2020 - 25% progression, died in committee
Action: 2020-05-13 - Read twice and referred to the Committee on Foreign Relations.
Pending: Senate Foreign Relations Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Authorizes a bilateral grant program with Israel to develop health technologies, with an emphasis on the use of technology, personalized medicine, and data in relation to COVID-19 (i.e., coronavirus disease 2019). Technologies to be developed through this program include, among others, artificial intelligence, respiratory assist devices, and diagnostic tests. In addition, the program conditions funding on a matching contribution from the government of Israel.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

EMPIL-DOC Act Expanding Medical Partnerships with Israel to Lessen Dependence On China Act

Sponsors


History

DateChamberAction
2020-05-13SenateRead twice and referred to the Committee on Foreign Relations.

Same As/Similar To

HB6829 (Related) 2020-05-12 - Referred to the House Committee on Energy and Commerce.
SB3176 (Related) 2020-06-03 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.
SB4537 (Related) 2020-09-08 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback